MAXITROL (DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYX) — FDA Approval ANDA062341 (SANDOZ)
MAXITROL (DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYX) — FDA Approval ANDA062341 (SANDOZ) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: MAXITROL; Active ingredients: DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; Application number: ANDA062341.
| Brand name | MAXITROL |
|---|---|
| Active ingredients | DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Application number | ANDA062341 |
| Sponsor | SANDOZ |
| Dosage form | SUSPENSION/DROPS |
| Route | OPHTHALMIC |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 19840522 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →